HAEMONETICS CORP — Investor Relations & Filings

Haemonetics Corporation is a global medical technology company that provides a suite of innovative solutions designed to improve the quality, effectiveness, and efficiency of healthcare. The company's portfolio serves customers across hospitals, blood centers, and plasma collection centers. Its business focuses on three key areas: Hospital, Plasma, and Blood Center. The Hospital division offers products for hemostasis management, such as TEG® systems; cell salvage systems, including Cell Saver®; and vascular closure devices. For the plasma and blood collection markets, Haemonetics provides automated collection technology, software, and services to manage the blood supply chain from donor to patient. The company's offerings encompass a range of devices, disposables, and information management solutions aimed at advancing patient care.